Dependence of TIMP-1 plasma levels on preanalytical specimen handling

Tumor Biology

Volumn 29, Issue 1, 2008, Pages 35-40

  Dresse, Marie ^a   Nagel, Dorothea ^a   Ganser, Eva Maria ^a   Davis, Gerard ^b   Dowell, Barry ^b   Doss, Robert ^b   Stieber, Petra ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ABBOTT DIAGNOSTICS   (United States)

Author keywords

Freezing thawing; Handling; Preanalytical; Stability; Storage; Tissue inhibitor of metalloproteinases 1

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CENTRIFUGATION; FREEZE THAWING; HUMAN; LABORATORY DIAGNOSIS; NORMAL HUMAN; PRIORITY JOURNAL; STORAGE; VOLUNTEER;

EID: 44349165000     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000132569     Document Type: Article

References (23)

1. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J: Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 1994;70:506-512.
2. Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Hoyer-Hansen G, Brünner N, Stephens RW: Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer 1999;80:495-503.
3. Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sorensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N: Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res 2002;8:156-164.
4. Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G: Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 2000;20:1085-1091.
5. Holten-Andersen MN, Nielsen HJ, Sorensen S, Jensen V, Brünner N, Christensen IJ: Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. Eur J Cancer 2006;42:1889-1896.
6. Sorensen NM, Byström P, Christensen IJ, Berglund A, Nielsen HJ, Brünner N, Glimelius B: TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid. Clin Cancer Res 2007;13:4117-4122.
7. Lipton A, Ali SM, Leitzel K, Demers L, Evans DB, Hamer P, Brown-Shimer S, Pierce K, Carney W: Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer. Cancer 2007;109:1933-1939.
8. Derosa G, D'Angelo A, Tinelli C, Devangelio E, Consoli A, Miccoli R, Penno G, Del Prato S, Paniga S, Cicero AF: Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab 2007;33:129-134.
9. Kralisch S, Bluher M, Tonjes A, Lossner U, Paschke R, Stumvoll M, Fasshauer M: Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. Eur J Endicrinol 2007;156:257-261.
10. Glowinska-Oleszewska B, Urban M: Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 2007;56:799-805.
11. Jguirim-Souissi I, Jelassi A, Addad F, Ben Farhat M, Bouslema A, Rouis M, Slimane MN: Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease. Am J Cardiol 2007;100:23-27.
12. McGavigan AD, Maxwell PR, Dunn FG: Serological evidence of early remodelling in high-risk non-ST elevation acute coronary syndromes. Int J Cardiol 2008;125:22-27.
13. Elmas E, Lang S, Erik Dempfle C, Kälsch T, Hannak D, Sueselbeck T, Wolpert C, Borggrefe M, Brueckmann M: High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction. Clin Chem Lab Med 2007;45:1360-1365.
14. Giansante C, Fiotti N, Di Chiara A, Altamura N, Wasserman S, Fioretti P, Guarnieri G: In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodelling markers. J Cardiovasc Med (Hagerstown) 2007;8:602-607.
15. Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 2006;151:1101.e1-e8.
16. Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M: Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 2006;38:867-872.
17. Lein M, Nowak L, Jung K, Koenig F, Lichtinghagen R, Schnorr D, Loening SA: Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. Clin Biochem 1997;30:491-496.
18. Imafuku Y, Meguro S, Kanno K, Hiraki H, Nemoto U, Hata R, Takahashi K, Miura Y, Yoshida H: The effect of EDTA contaminated in sera on laboratory data. Clin Chim Acta 2002;325:105-111.
19. Holten-Andersen MN, Schrohl AS, Brünner N, Nielsen HJ, Høgdall CK, Høgdall EV: Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay. Int J Biol Markers 2003;18:170-176.
20. Jung K: Preanalytical biases in measurement of matrix metalloproteinases and their inhibitors in peripheral blood. J Rheumatol 2007;34:890-892.
21. Alby C, Ben Abdesselam O, Foglietti MJ, Beaudeux JL: Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in blood. Clin Chim Acta 2002;325:183-186.
22. Lomholt AF, Frederiksen CB, Christensen IJ, Brünner N, Nielsen HJ: Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations. Clin Chim Acta 2007;380:128-132.
23. Cooper TW, Eisen AZ, Stricklin GP, Welgus HG: Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci USA 1985;82:2779-2783.